Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30

$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cryo-Cell International's pe ratio was 519.0× on Jun 30, 2025, against 19.0× a year earlier. Over the last 5 years it ranged from 9.2× to 525.0×, with a median of 23.6×.

PE Ratio at the end of each year

Period	Period end	Value	Change (pts)
2025	Jun 30, 2025	519.0×	+499.8
2023	Dec 29, 2023	19.2×	−7.3
2022	Dec 30, 2022	26.4×	+1.8
2021	Dec 31, 2021	24.7×	+5.4
2020	Dec 31, 2020	19.3×	−6.2
2019	Dec 31, 2019	25.5×	+0.8
2018	Mar 29, 2018	24.6×	−4.7
2017	Dec 29, 2017	29.3×	+24.7
2016	Sep 30, 2016	4.6×	+0.7
2015	Dec 31, 2015	3.9×	−36.9
2014	Dec 31, 2014	40.8×	+33.5
2011	Sep 30, 2011	7.3×	–

Where these numbers come from

Parsed from the XBRL in Cryo-Cell International's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing